Akums Drugs and Pharmaceuticals Limited (BOM:544222)
814.70
+14.10 (1.76%)
At close: Oct 6, 2026
BOM:544222 Market Cap
BOM:544222 has a market cap or net worth of 124.72 billion as of October 7, 2026. Its market cap has increased by 82.58% in one year.
Market Cap
124.72B
Enterprise Value
110.01B
Revenue
45.04B
Global Rank
n/a
Country Rank
n/a
PE Ratio
42.75
ChartMarket Cap Chart
Since August 6, 2024, BOM:544222's market cap has decreased from 125.32B to 124.72B, a decrease of -0.48%. That is a compound annual growth rate of -0.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 124.72B | 79.68% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 207.20B |
| Caplin Point Laboratories | 203.65B |
| Jubilant Pharmova | 156.49B |
| AstraZeneca Pharma India | 149.58B |
| Viyash Scientific | 101.91B |
| Procter & Gamble Health | 88.01B |
| Morepen Laboratories | 78.77B |
| Bliss GVS Pharma | 71.25B |